	Out-of-Pocket Expenses in Patients with Psoriasis: A Study from a Tertiary Care Hospital in North India. Indian Dermatol Online J Bhandari A, Narang S, Narang T, Kavita, Handa S, Dogra S, Prinja S. PMID: 42041242 [PubMed - as supplied by publisher]
	Immunoregulation by DC and T cells in psoriasis with probable immunotherapeutic approaches. Int Rev Immunol Kundu S, Paul R, Chakraborty K. PMID: 42041098 [PubMed - as supplied by publisher]
	Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis : Molecular Pathogenesis of Psoriasis. Galen Med J Shokoufa P, Aghaei M. PMID: 42038851 [PubMed]
	Comments on Chiu et al.'s " Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: A 15-year multicenter cohort study". J Am Acad Dermatol Xiao Y, Li S, Cao X. PMID: 42036024 [PubMed - as supplied by publisher]
	Response to Bar et al.'s "Cancer progression, recurrence, and infection outcomes in psoriasis patients with active or recent malignancy treated with biologic therapy: A cohort study showing comparable safety to conventional agents". J Am Acad Dermatol Chen B, Yang L, Wang J, Hu T. PMID: 42036022 [PubMed - as supplied by publisher]
	Deucravacitinib in Moderate-to-Severe Plaque Psoriasis: A Real-World Study of Effectiveness and Safety in Clinical Practice. Clin Exp Dermatol Ruggiero A, Mozzillo R, Cordedda M, Camela E, Zanchini R, Colasanti P, Zagaria O. PMID: 42035362 [PubMed - as supplied by publisher]
	Reframing molecular superiority in the differential diagnosis of eczema and psoriasis. J Eur Acad Dermatol Venereol Sun M, Zang D, Chen J. PMID: 42033216 [PubMed - as supplied by publisher]
	Granulomatous prostatitis masquerading as suspected prostate cancer in a young patient on immunotherapy for psoriasis. BMJ Case Rep Guduguntla A, Ryan A, Sim K, Satasivam P. PMID: 42031391 [PubMed - indexed for MEDLINE]
	Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study. Dermatol Ther (Heidelb) Facheris P, Piscazzi F, Fiorillo G, Valenti M, Costanzo A, Borroni RG. PMID: 42029886 [PubMed - as supplied by publisher]
	3D-Printed lesion-conformal light-guiding patches for precise and personalized psoriasis phototherapy. Biomater Sci Wang Y, Mei L, Wan T, Fu Y, Xue X, Guo W, Wang Y, Zhao Y, Liu R. PMID: 42029092 [PubMed - as supplied by publisher]
	Prevalence and risk factors of fatty liver disease in psoriasis: A systematic review and meta-analysis based on NAFLD/MAFLD diagnostic criteria. JAAD Int Shen J, Liu L, Wang J, Cai X, Zhang M, Wang Q, Li X, Sun X. PMID: 42027986 [PubMed]
	A Study on Early Screening and Disease Characteristics of Psoriatic Arthritis Based on PEST Questionnaire and Musculoskeletal Ultrasound. J Inflamm Res Wei J, Guo Y, Ma J, Luo S, Li Y, Zhou Q, Tong X, Wang Z, Wang H. PMID: 42027255 [PubMed]
	Diagnosis and therapeutic management of psoriatic arthritis: summary of 2024 update of the Spanish clinical practice guideline (ESPOGUIA). Ther Adv Musculoskelet Dis Ramírez J, López-Medina C, Montilla C, Moreno M, Moreno MJ, Navarro V, Díaz D, Fernández-Clotet A, Riera-Monroig J, Díaz-Del Campo P, Cañete JD, Queiro R. PMID: 42027204 [PubMed]
	Predictors of early high-level response to bimekizumab in patients with moderate-to-severe plaque psoriasis: a real-world cohort study. An Bras Dermatol Engin B, Demir Y, Yildirim G, Diken FZ, Yildiz B, Kutlubay Z, Serdaroglu S. PMID: 42025118 [PubMed - as supplied by publisher]
	Subclinical Enthesitis in Psoriasis Patients as Predictors of Arthritis: The EPESCA Study. J Psoriasis Psoriatic Arthritis Di Donato E, Becciolini A, Di Nuzzo S, Chernyschova N, Commisso C, Lamorte S, Fantini C, Satolli F, Santilli D, Lucchini G, Feliciani C, Sverzellati N, Ariani A. PMID: 42021782 [PubMed - as supplied by publisher]
	Comparing the efficacy and safety of biosimilar BAT2506 with reference golimumab in patients with active psoriatic arthritis: 24-week results of a phase 3, multicenter, double-blind, randomized, parallel-group study. Expert Opin Biol Ther Tang H, Dokoupilova E, Batko B, Zawadzki M, Batalov A, Liu Y, Yang X, Zhou Y, Dong Q, Liu Y. PMID: 42021476 [PubMed - as supplied by publisher]
	Comparative risk of serious infections across biological drugs in patients with psoriatic arthritis or psoriasis: A target trial emulation using the Italian VALORE distributed database network. Pharmacol Res Spini A, L'Abbate L, Ingrasciotta Y, Carollo M, Bellitto C, Leoni O, Zanforlini M, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Ledda S, Carta P, Rossi P, Ejlli L, Sapigni E, Puccini A, Scarpelli RF, De Sarro G, Allotta A, Addario Pollina S, Da Cas R, Bucaneve G, Mangano AMP, Balducci F, Sorrentino C, Senesi I, Tuccori M, Gini R, Trama U, Bernardi FF, Mayer F, Alegiani SS, Massari M, Guarneri C, Gisondi P, Fontana A, Patorno E, Trifirò G. PMID: 42019563 [PubMed - as supplied by publisher]
	Genetic Evidence Linking Immune Cell Subsets to Psoriatic Arthritis Susceptibility: A Mendelian Randomization Study. Psoriasis (Auckl) Wang H, Ma M, Wang C, Zhen Y, Li S. PMID: 42016305 [PubMed]
	Role of the STAT3 Signaling Pathway in Cell Proliferation and Inflammation in Psoriasis and Approaches for Targeted Therapies: A Review. Med Sci Monit Li L, Chen L, Zhang C, Yao W, Li Z, Tian F. PMID: 42015469 [PubMed - indexed for MEDLINE]
	International consensus on dose reduction of biologics for patients with psoriasis: The DR. Delphi study. J Eur Acad Dermatol Venereol van Riel CAM, Boehncke WH, Lambert JLW, Spuls PI, van der Schoot LS, van Ee I, de Jong EMGJ, van den Reek JMPA, eDelphi consortium. PMID: 42012299 [PubMed - as supplied by publisher]

Articles 1 - 20 / 27808

Page 1 of 1391



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy